Baduanjin Program Effect on Geriatric Functional Dyspepsia

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05915520

Enrollment

Registered

2023-06-23

Start date

2023-07-20

Completion date

2024-01-30

Last updated

2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Brief summary

functional dyspepsia is very common between geriatric population

Detailed description

Forty Egyptian geriatrics with functional dyspepsia, after randomization, will be divided to 2 groups; the first 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug. in the other 20-geriatric group, the daily dose of drug will be administered only for 8 weeks .

Interventions

BEHAVIORALbaduinjuin activities

in this 20-geriatric group will receive 5-session per-week 40-minute baduinjuin for 8 weeks plus the daily dose of pantoprazole (40 mg orally administered tablet drug)

OTHERpantoprazole

in this 20-geriatric group will receive the daily dose of pantoprazole (40 mg orally administered tablet drug for 8 weeks .

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

65 Years to 75 Years

Healthy volunteers

Inclusion criteria

* functional dyspepsia complaints * geriatric population

Exclusion criteria

* cardiac complaints * respiratory complaints * articular complaints

Design outcomes

Primary

Measure	Time frame	Description
cortisol	It will be measured after 8 weeks	it is a serum stress marker

Secondary

Measure	Time frame	Description
depression sub component of Hospital anxiety and depression scale	It will be measured after 8 weeks	It will be measure depression
anxiety sub component of Hospital anxiety and depression scale	It will be measured after 8 weeks	It will be measure anxiety
Glasgow dyspepsia severity score	It will be measured after 8 weeks	It will be used to assess functional dyspepsia
visual analogue scale	It will be measured after 8 weeks	It will be used to assess abdominal symptoms of geriatric patients regarding functional dyspepsia

Countries

Egypt

Contacts

Primary ContactAli MA Ismail

ali.mohamed@pt.cu.edu.eg01005154209

Backup ContactAli MA Ismail, lecturer

ali.mohamed@pt.cu.edu.eg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026